Purchases and Sales Made in Q4 2023 in Cue Biopharma, Inc. (CUE)
This table provides information about the institutional ownership of Cue Biopharma, Inc. (CUE) during Q4 2023. The information is specifically focused on institutions that hold shares of Cue Biopharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2024
Q4 2023
|
Xtx Topco LTD
London, X0 |
SELL
|
- |
-38K- 71.27% |
$65.3K - $118K
|
15.3K
$20.5K
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-48.4K- 48.77% |
$83.2K - $150K
|
50.8K
$68.1K
|
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-48.8K- 62.37% |
$83.9K - $151K
|
29.4K
$39.4K
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-58.9K- 80.91% |
$101K - $182K
|
13.9K
$18.6K
|
|
|
Feb 07, 2024
Q4 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-109K- 19.17% |
$187K - $337K
|
458K
$614K
|
|
|
Feb 01, 2024
Q4 2023
|
Sigma Planning Corp
Ann Arbor, MI |
SELL
|
- |
-136K- 55.51% |
$234K - $421K
|
109K
$146K
|